The company
Pacific Biosciences of California, Inc.
PACB · Nasdaq
PACB stood above a rising 150-day average in 18 of the last 52 weekly readings, including each of the last 2 weeks. It is 22.7% above that average now. Life Science Tools & Research Services: 54% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 54% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $4.7M
- Officials’ trades on record
- 0
- Institutions holding
- 214 (-4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| James R. Gibson IIOfficer | sold | 661,815at $3.11 | 6 Oct 2026filed 8 Oct 2026 |
| Oene Mark VanOfficer | sold | 26,911at $1.13 | 17 Aug 2026filed 18 Aug 2026 |
| James R. Gibson IIOfficer | sold | 88,185at $1.37 | 1 Apr 2026filed 3 Apr 2026 |
| Michele FarmerOfficer | sold | 2,979at $1.51 | 3 Mar 2026filed 4 Mar 2026 |
| Oene Mark VanOfficer | sold | 6,504at $1.51 | 3 Mar 2026filed 4 Mar 2026 |
| Christian O. HenryOfficer | sold | 12,497at $1.51 | 3 Mar 2026filed 4 Mar 2026 |
| Michele FarmerOfficer | sold | 14,952at $1.63 | 18 Feb 2026filed 19 Feb 2026 |
| Christian O. HenryOfficer | sold | 140,874at $1.63 | 18 Feb 2026filed 19 Feb 2026 |
| Oene Mark VanOfficer | sold | 55,107at $1.63 | 18 Feb 2026filed 19 Feb 2026 |
| Michele FarmerOfficer | sold | 35,215at $1.58 | 17 Feb 2026filed 19 Feb 2026 |
| Christian O. HenryOfficer | sold | 331,793at $1.58 | 17 Feb 2026filed 19 Feb 2026 |
| Oene Mark VanOfficer | sold | 129,790at $1.58 | 17 Feb 2026filed 19 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 32,339,550$54.3M | +7,072,121+28.0% |
| ARK Investment Management LLCreduced · filed 14 Aug 2026 | 29,781,416$50.0M | -6,491,872−17.9% |
| SOFTBANK GROUP CORP.unchanged · filed 14 Aug 2026 | 20,451,570$34.4M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 13,397,934$22.5M | +620,485+4.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 7,606,518$12.8M | +631,252+9.0% |
| Sumitomo Mitsui Trust Group, Inc.reduced · filed 30 Jul 2026 | 6,009,715$10.1M | -1,028,272−14.6% |
| Amova Asset Management Americas, Inc.reduced · filed 13 Aug 2026 | 6,009,715$10.0M | -1,028,272−14.6% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 5,961,175$10.0M | -160,541−2.6% |
| Point72 Asset Management, L.P.added · filed 14 Aug 2026 | 4,787,300$8.0M | +4,501,600+1575.6% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 4,242,599$7.1M | +732,986+20.9% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.